{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:25:30Z","timestamp":1791944730869,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In brain-dead donor resuscitation, hydroxyethyl starch (HES) use has been associated with presence of osmotic-nephrosis-like lesions in kidney transplant recipients. Our aim was to determine whether the presence of HES in protocol renal graft biopsies at three months (M3) after transplantation is associated with renal graft quality. According to the HES administered to the donor during the procurement procedure, two groups of patients were defined according graft exposition to HES: HES group, (N\u2009=\u200920) and control group (N\u2009=\u20096). Detection and relative quantification of HES was performed by Raman spectroscopy microimaging on M3 protocol renal graft biopsies. Statistical analyses were used to investigate the association between Raman data and graft characteristics. HES spectral signal was revealed negative in the control group, whereas it was positive in 40% of biopsies from the HES group. In the HES group, a stronger HES signal was associated with a lower risk of graft failure measured by the Kidney Donor Risk Index (KDRI) and was correlated with the allograft kidney function. Thus, HES accumulation in donor kidney, as probed by Raman biophotonic technique, is correlated with the quality of donor kidney and consequently the graft renal function and graft survival.<\/jats:p>","DOI":"10.1038\/srep33045","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T10:18:37Z","timestamp":1473416317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Raman-based detection of hydroxyethyl starch in kidney allograft biopsies as a potential marker of allograft quality in kidney transplant recipients"],"prefix":"10.1038","volume":"6","author":[{"given":"Vincent","family":"Vuiblet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezechiel","family":"Bankole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Wynckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Gobinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Birembaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Piot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"BFsrep33045_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/ajt.12090","volume":"13","author":"DJ Malinoski","year":"2013","unstructured":"Malinoski, D. J. et al. The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients. Am J Transplant 13, 993\u20131000 (2013).","journal-title":"Am J Transplant"},{"key":"BFsrep33045_CR2","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/CCM.0b013e31825b252a","volume":"40","author":"DJ Malinoski","year":"2012","unstructured":"Malinoski, D. J., Patel, M. S., Daly, M. C., Oley-Graybill, C. & Salim, A. The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Critical care medicine 40, 2773\u20132780 (2012).","journal-title":"Critical care medicine"},{"key":"BFsrep33045_CR3","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1503\/cmaj.045131","volume":"174","author":"SD Shemie","year":"2006","unstructured":"Shemie, S. D. et al. Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. Cmaj 174, S13\u201332 (2006).","journal-title":"Cmaj"},{"key":"BFsrep33045_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst, F. M. et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England journal of medicine 358, 125\u2013139, doi: 10.1056\/NEJMoa070716 (2008).","journal-title":"The New England journal of medicine"},{"key":"BFsrep33045_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/s0140-6736(00)04211-2","volume":"357","author":"F Schortgen","year":"2001","unstructured":"Schortgen, F. et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357, 911\u2013916, doi: 10.1016\/s0140-6736(00)04211-2 (2001).","journal-title":"Lancet"},{"key":"BFsrep33045_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/CCM.0b013e318212096a","volume":"39","author":"O Bayer","year":"2011","unstructured":"Bayer, O. et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Critical care medicine 39, 1335\u20131342, doi: 10.1097\/CCM.0b013e318212096a (2011).","journal-title":"Critical care medicine"},{"key":"BFsrep33045_CR7","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","volume":"367","author":"JA Myburgh","year":"2012","unstructured":"Myburgh, J. A. et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. The New England journal of medicine 367, 1901\u20131911, doi: 10.1056\/NEJMoa1209759 (2012).","journal-title":"The New England journal of medicine"},{"key":"BFsrep33045_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner, A. et al. Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. The New England journal of medicine 367, 124\u2013134, doi: 10.1056\/NEJMoa1204242 (2012).","journal-title":"The New England journal of medicine"},{"key":"BFsrep33045_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0140-6736(93)92345-T","volume":"342","author":"C Legendre","year":"1993","unstructured":"Legendre, C. et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342, 248\u2013249 (1993).","journal-title":"Lancet"},{"key":"BFsrep33045_CR10","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0750-7658(05)80741-5","volume":"13","author":"C Legendre","year":"1994","unstructured":"Legendre, C. & Atinault, A. [Hydroxyethylstarch and osmotic nephrosis]. Annales francaises d\u2019anesthesie et de reanimation 13, 766\u2013767 (1994).","journal-title":"Annales francaises d\u2019anesthesie et de reanimation"},{"key":"BFsrep33045_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00134-013-3156-9","volume":"40","author":"CJ Wiedermann","year":"2014","unstructured":"Wiedermann, C. J. & Joannidis, M. Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40, 160\u2013170 (2014).","journal-title":"Intensive Care Med"},{"key":"BFsrep33045_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1053\/j.ajkd.2007.10.044","volume":"51","author":"M Dickenmann","year":"2008","unstructured":"Dickenmann, M., Oettl, T. & Mihatsch, M. J. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. American journal of kidney diseases: the official journal of the National Kidney Foundation 51, 491\u2013503, doi: 10.1053\/j.ajkd.2007.10.044 (2008).","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"BFsrep33045_CR13","doi-asserted-by":"crossref","unstructured":"Farhane, Z., Bonnier, F., Casey, A. & Byrne, H. J. Raman micro spectroscopy for in vitro drug screening: subcellular localisation and interactions of doxorubicin. Analyst (2015).","DOI":"10.1039\/C5AN00256G"},{"key":"BFsrep33045_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00216-003-2266-6","volume":"378","author":"C Krafft","year":"2004","unstructured":"Krafft, C. Bioanalytical applications of Raman spectroscopy. Analytical and bioanalytical chemistry 378, 60\u201362, doi: 10.1007\/s00216-003-2266-6 (2004).","journal-title":"Analytical and bioanalytical chemistry"},{"key":"BFsrep33045_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00249-007-0191-x","volume":"36","author":"A Tfayli","year":"2007","unstructured":"Tfayli, A., Piot, O., Pitre, F. & Manfait, M. Follow-up of drug permeation through excised human skin with confocal Raman microspectroscopy. European biophysics journal: EBJ 36, 1049\u20131058, doi: 10.1007\/s00249-007-0191-x (2007).","journal-title":"European biophysics journal: EBJ"},{"key":"BFsrep33045_CR16","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1039\/c0an00998a","volume":"136","author":"F Draux","year":"2011","unstructured":"Draux, F. et al. Raman imaging of single living cells: probing effects of non-cytotoxic doses of an anti-cancer drug. The Analyst 136, 2718\u20132725, doi: 10.1039\/c0an00998a (2011).","journal-title":"The Analyst"},{"key":"BFsrep33045_CR17","unstructured":"US Food and Drug Administration, F. Hydroxyethyl Starch Solutions: FDA Safety Communication - Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding, http:\/\/www.fda.gov\/safety\/medwatch\/safetyinformation\/safetyalertsforhumanmedicalproducts\/ucm358349.htm (date of access 06\/11\/13) (posted 2013)."},{"key":"BFsrep33045_CR18","unstructured":"Agency, E. M. Hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients \u2013 CMDh endorses PRAC recommendations, http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Hydroxyethyl_starch-containing_solutions\/human_referral_prac_000012.jsp&mid=WC0b01ac05805c516f (date of access 06\/03\/2014) (posted 2013)."},{"key":"BFsrep33045_CR19","doi-asserted-by":"publisher","first-page":"f6197","DOI":"10.1136\/bmj.f6197","volume":"347","author":"S Mayor","year":"2013","unstructured":"Mayor, S. EMA confirms that hydroxyethyl starch solutions should not be used in critically ill, sepsis, or burns patients. BMJ (Clinical research ed.) 347, f6197, doi: 10.1136\/bmj.f6197 (2013).","journal-title":"BMJ (Clinical research ed.)"},{"key":"BFsrep33045_CR20","doi-asserted-by":"crossref","unstructured":"Vuiblet, V. et al. Contribution of Raman spectroscopy in nephrology: a candidate technique to detect hydroxyethyl starch of third generation in osmotic renal lesions under soumission (2015).","DOI":"10.1039\/C5AN00821B"},{"key":"BFsrep33045_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2165\/00003088-200544070-00002","volume":"44","author":"C Jungheinrich","year":"2005","unstructured":"Jungheinrich, C. & Neff, T. A. Pharmacokinetics of hydroxyethyl starch. Clinical pharmacokinetics 44, 681\u2013699 (2005).","journal-title":"Clinical pharmacokinetics"},{"key":"BFsrep33045_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2165\/00126839-200304060-00001","volume":"4","author":"J Leuschner","year":"2003","unstructured":"Leuschner, J., Opitz, J., Winkler, A., Scharpf, R. & Bepperling, F. Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130\/0.4 and HES 200\/0.5 after repeated intravenous administration to rats. Drugs in R&D 4, 331\u2013338 (2003).","journal-title":"Drugs in R&D"},{"key":"BFsrep33045_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/bja\/82.4.510","volume":"82","author":"C Sirtl","year":"1999","unstructured":"Sirtl, C., Laubenthal, H., Zumtobel, V., Kraft, D. & Jurecka, W. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. British journal of anaesthesia 82, 510\u2013515 (1999).","journal-title":"British journal of anaesthesia"},{"key":"BFsrep33045_CR24","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/cc7726","volume":"13","author":"L Huter","year":"2009","unstructured":"Huter, L. et al. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Critical care (London, England) 13, R23, doi: 10.1186\/cc7726 (2009).","journal-title":"Critical care (London, England)"},{"key":"BFsrep33045_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ki.1979.132","volume":"16","author":"EI Christensen","year":"1979","unstructured":"Christensen, E. I. & Maunsbach, A. B. Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule. Kidney Int 16, 301\u2013311 (1979).","journal-title":"Kidney Int"},{"key":"BFsrep33045_CR26","doi-asserted-by":"crossref","unstructured":"Lee, A. P. & Abramowicz, D. Is the Kidney Donor Risk Index a step forward in the assessment of deceased donor kidney quality? Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association (2014).","DOI":"10.1093\/ndt\/gfu304"},{"key":"BFsrep33045_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/TP.0b013e3181ac620b","volume":"88","author":"PS Rao","year":"2009","unstructured":"Rao, P. S. et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 88, 231\u2013236 (2009).","journal-title":"Transplantation"},{"key":"BFsrep33045_CR28","first-page":"F1063","volume":"267","author":"M Brezis","year":"1994","unstructured":"Brezis, M., Heyman, S. N. & Epstein, F. H. Determinants of intrarenal oxygenation. II. Hemodynamic effects. The American journal of physiology 267, F1063\u20131068 (1994).","journal-title":"The American journal of physiology"},{"key":"BFsrep33045_CR29","first-page":"272","volume":"14","author":"G Costamagna","year":"2010","unstructured":"Costamagna, G. & Marchese, M. Progress in endoscopic imaging of gastrointestinal tumors. European review for medical and pharmacological sciences 14, 272\u2013276 (2010).","journal-title":"European review for medical and pharmacological sciences"},{"key":"BFsrep33045_CR30","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1158\/0008-5472.can-11-4061","volume":"72","author":"H Lui","year":"2012","unstructured":"Lui, H., Zhao, J., McLean, D. & Zeng, H. Real-time Raman spectroscopy for in vivo skin cancer diagnosis. Cancer research 72, 2491\u20132500, doi: 10.1158\/0008-5472.can-11-4061 (2012).","journal-title":"Cancer research"},{"key":"BFsrep33045_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/lsm.22318","volume":"47","author":"FL Silveira","year":"2015","unstructured":"Silveira, F. L. et al. Discrimination of non-melanoma skin lesions from non-tumor human skin tissues in vivo using Raman spectroscopy and multivariate statistics. Lasers in surgery and medicine 47, 6\u201316, doi: 10.1002\/lsm.22318 (2015).","journal-title":"Lasers in surgery and medicine"},{"key":"BFsrep33045_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.critrevonc.2009.09.004","volume":"72","author":"A Beljebbar","year":"2009","unstructured":"Beljebbar, A. et al. Identification of Raman spectroscopic markers for the characterization of normal and adenocarcinomatous colonic tissues. Critical reviews in oncology\/hematology 72, 255\u2013264, doi: 10.1016\/j.critrevonc.2009.09.004 (2009).","journal-title":"Critical reviews in oncology\/hematology"},{"key":"BFsrep33045_CR33","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1364\/boe.6.002380","volume":"6","author":"J Desroches","year":"2015","unstructured":"Desroches, J. et al. Characterization of a Raman spectroscopy probe system for intraoperative brain tissue classification. Biomedical optics express 6, 2380\u20132397, doi: 10.1364\/boe.6.002380 (2015).","journal-title":"Biomedical optics express"},{"key":"BFsrep33045_CR34","doi-asserted-by":"publisher","first-page":"081421","DOI":"10.1117\/1.jbo.17.8.081421","volume":"17","author":"LM Almond","year":"2012","unstructured":"Almond, L. M. et al. Assessment of a custom-built Raman spectroscopic probe for diagnosis of early oesophageal neoplasia. Journal of biomedical optics 17, 081421\u2013081421, doi: 10.1117\/1.jbo.17.8.081421 (2012).","journal-title":"Journal of biomedical optics"},{"key":"BFsrep33045_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.surge.2011.02.004","volume":"10","author":"JD Horsnell","year":"2012","unstructured":"Horsnell, J. D. et al. Raman spectroscopy\u2013a potential new method for the intra-operative assessment of axillary lymph nodes. The surgeon: journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 10, 123\u2013127, doi: 10.1016\/j.surge.2011.02.004 (2012).","journal-title":"The surgeon: journal of the Royal Colleges of Surgeons of Edinburgh and Ireland"},{"key":"BFsrep33045_CR36","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1039\/c2an35170f","volume":"137","author":"KS Ock","year":"2012","unstructured":"Ock, K. S. et al. Label-free Raman spectroscopy for accessing intracellular anticancer drug release on gold nanoparticles. The Analyst 137, 2852\u20132859, doi: 10.1039\/c2an35170f (2012).","journal-title":"The Analyst"},{"key":"BFsrep33045_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bpc.2008.11.005","volume":"140","author":"J Guo","year":"2009","unstructured":"Guo, J., Cai, W., Du, B., Qian, M. & Sun, Z. Raman spectroscopic investigation on the interaction of malignant hepatocytes with doxorubicin. Biophysical chemistry 140, 57\u201361, doi: 10.1016\/j.bpc.2008.11.005 (2009).","journal-title":"Biophysical chemistry"},{"key":"BFsrep33045_CR38","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1021\/acs.analchem.5b01431","volume":"87","author":"SF El-Mashtoly","year":"2015","unstructured":"El-Mashtoly, S. F. et al. Label-Free Raman Spectroscopic Imaging Monitors the Integral Physiologically Relevant Drug Responses in Cancer Cells. Analytical chemistry 87, 7297\u20137304, doi: 10.1021\/acs.analchem.5b01431 (2015).","journal-title":"Analytical chemistry"},{"key":"BFsrep33045_CR39","doi-asserted-by":"publisher","first-page":"025001","DOI":"10.1117\/1.jbo.19.2.025001","volume":"19","author":"X Bi","year":"2014","unstructured":"Bi, X., Rexer, B., Arteaga, C. L., Guo, M. & Mahadevan-Jansen, A. Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy. Journal of biomedical optics 19, 025001, doi: 10.1117\/1.jbo.19.2.025001 (2014).","journal-title":"Journal of biomedical optics"},{"key":"BFsrep33045_CR40","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1111\/ajt.12830","volume":"14","author":"AB Massie","year":"2014","unstructured":"Massie, A. B. et al. Survival benefit of primary deceased donor transplantation with high-KDPI kidneys. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14, 2310\u20132316, doi: 10.1111\/ajt.12830 (2014).","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"BFsrep33045_CR41","doi-asserted-by":"crossref","unstructured":"Pelletier, R. P., Pesavento, T. E., Rajab, A. & Henry, M. L. High mortality in diabetic recipients of high KDPI deceased donor kidneys. Clinical transplantation, doi: 10.1111\/ctr.12768 (2016).","DOI":"10.1111\/ctr.12768"},{"key":"BFsrep33045_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/srt.12228","volume":"22","author":"M Essendoubi","year":"2016","unstructured":"Essendoubi, M. et al. Human skin penetration of hyaluronic acid of different molecular weights as probed by Raman spectroscopy. Skin research and technology: official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 22, 55\u201362, doi: 10.1111\/srt.12228 (2016).","journal-title":"Skin research and technology: official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep33045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33045","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:18:21Z","timestamp":1672881501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep33045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep33045"],"URL":"https:\/\/doi.org\/10.1038\/srep33045","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]},"assertion":[{"value":"29 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33045"}}